ArticleMedecine tropicale et sante internationale2025
[Polyarteritis nodosa: an etiology of myelitis that should not be ignored in subsaharansub-Saharan Africa].
Article in Medecine tropicale et sante internationale, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Polyarteritis nodosa (PAN) is a systemic necrotizing segmental vasculitis that affects medium-and small-caliber arteries. It is characterized by infiltration of the different layers of the arterial wall (adventitia, media, and intima) by neutrophils, lymphocytes, and eosinophils, resulting in a variety of clinical signs. This infiltration is responsible for reducing arterial caliber, which can range from minimal to severe and cause neurological and digestive manifestations. These manifestations are complicated by a deterioration in the patient's general condition, leading to diagnostic uncertainty in sub-Saharan Africa, where certain infectious diseases (e.g., HIV/AIDS, tuberculosis, and viral hepatitis) are endemic. We present two cases of PAN with initial peripheral neurological involvement (paraplegia and quadriplegia) secondary to transverse myelitis in patients with a history of fetal loss. Through these two case studies, we aim to clarify the characteristics of this rarely described association between PAN and antiphospholipid antibodies. Case reports: The patients, aged 25 and 45, presented with chronic migraines, miscarriages, and a major peripheral neurological deficit that occurred during the dry season (the low-temperature season in Gabon). Magnetic resonance imaging revealed transverse myelitis. An exhaustive autoimmune assessment yielded only a positive result for circulating lupus anticoagulant. Discussion: Although we diagnosed polyarteritis nodosa in these two patients, the role of the lupus anticoagulants remains debatable. These antiphospholipid antibodies are likely to create the conditions for vasculitis due to its persistence in the serum even in the absence of disease activity. Conclusion: The combination of corticosteroid therapy, immunosuppressants, and intensive physical therapy resulted in satisfactory neurological recovery at six and seven months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.